SNCA and Parkinson disease: Metformin-evoked AMPK activation not only reduces inflammation but also increases microglial phagocytic activity, which is essential for the removal of pathologic protein aggregates like alpha-synuclein in PD and Aβ in AD (Alrouji et al. 2024a).